Medical treatment of peripheral arterial disease and claudication.

By W. Hiatt. New England Journal of Medicine, 2001

1,141 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/700ea3bfaf3562b1772a7914f9b8c8e6a4da89d0

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. I. Graham
2. T. Ivanova

In Pulmonary and Respiratory Medicine

1. I. Graham
2. T. Ivanova

In Surgery

1. I. Graham
2. T. Ivanova
3. Alberico L. Catapano

Citations in the corpus

• 2016 European Guidelines on cardiovascular disease prevention in clinical practice (2017, neutral): “90 is considered to be a reliable marker of peripheral artery disease (PAD) [129].”
• Guidelines on cardiovascular disease prevention in clinical practice: the European perspective (2005, neutral): “90 is considered to be a reliable marker of peripheral artery disease 1005 (PAD).(131) An ABI value indicating significant PAD adds value to medical history, because 1006 50–89% of patients with an ABI <0.”
• 2016 European Guidelines on cardiovascular disease prevention in clinical practice (2016, background): “90 is considered to be a reliable marker of peripheral artery disease (PAD).(129) An ABI value indicating significant PAD adds value to the medical history, because 50–89% of patients with an ABI ,0.”
• European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) (2012, neutral): “90 is considered to be a reliable marker of PAD.(133) An ABI value indicating significant PAD adds additional value to medical history, because 50–89% of patients with an ABI ,0.”
• Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. (2004, background): “90 due to calcification of lowerextremity arteries, resulting in falsely elevated lower-extremity pressures.(48) Our study has some weaknesses.”
• Androgens and cardiovascular disease. (2003, neutral): “Peripheral arterial disease (PAD), as the manifestation of atherosclerotic arterial disease affecting the pelvis and legs, has been comprehensively reviewed recently (363, 364).”
• 2016 European Guidelines on cardiovascular disease prevention in clinical practice. (2016, background): “90 is considered to be a reliable marker of peripheral artery disease (PAD).(129) An ABI value indicating significant PAD adds value to the medical history, because 50–89% of patients with an ABI ,0.”